Assessment of major gaps

Dec 19, 2019

Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.

Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.

Recent News

Sunitinib efficacy in Pheochromocytoma and Paraganglioma

Sunitinib efficacy in Pheochromocytoma and Paraganglioma

#ESMO2021 Rare NETs: Sunitinib efficacy in #Pheochromocytoma and #Paraganglioma - "A strong result for a treatment based on sound mechanistic principle," says Prof Juan Valle, University of Manchester & Dept of Medical Oncology at The Christie NHS Foundation...

read more
King’s Patient Education Event

King’s Patient Education Event

We are delighted to once again be working alongside the King’s Healthcare Partners (KHP) ENETs Centre of Excellence on their annual Patient Education Event.

read more
Gynaecological Neuroendocrine Cancer

Gynaecological Neuroendocrine Cancer

September is Gynaecological Cancer Awareness Month (GCAM). Gynaecological cancer refers to cancers that start in 5 of the main parts of the female reproductive system – ovary, womb (uterine or endometrium), cervix, vagina and vulva. Sex assigned at birth, hormones...

read more